108 related articles for article (PubMed ID: 11187896)
1. Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies.
Van Gool SW; Van Kerschaver E; Brock P; Pottel H; Hulstaert F; Vanmechelen E; Uyttebroeck A; Van De Voorde A; Vanderstichele H
Leukemia; 2000 Dec; 14(12):2076-84. PubMed ID: 11187896
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for acute lymphoblastic leukemia.
Van Gool SW; De Meyer G; Van de Voorde A; Vanmechelen E; Vanderstichele H
Neurotoxicology; 2004 Mar; 25(3):471-80. PubMed ID: 15019310
[TBL] [Abstract][Full Text] [Related]
3. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
4. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
[TBL] [Abstract][Full Text] [Related]
5. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM
JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal chemotherapy with antineoplastic agents in children.
Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive Sequelae in Adult Childhood Leukemia Survivors Related to Levels of Phosphorylated Tau.
Elens I; Deprez S; Danckaerts M; Bijttebier P; Labarque V; Uyttebroeck A; Van Gool S; D'Hooge R; Lemiere J
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 29982754
[TBL] [Abstract][Full Text] [Related]
8. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.
Reisbach G; Kamp T; Welzl G; Geiz C; Abedinpour Fariborz ; Lodri A; Kaboth W; Dörmer P; Nerl C
Br J Haematol; 1996 Mar; 92(4):907-12. PubMed ID: 8616084
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.
Gavhed D; Akefeldt SO; Osterlundh G; Laurencikas E; Hjorth L; Blennow K; Rosengren L; Henter JI
Pediatr Blood Cancer; 2009 Dec; 53(7):1264-70. PubMed ID: 19688833
[TBL] [Abstract][Full Text] [Related]
10. Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification.
Yamamori H; Khatoon S; Grundke-Iqbal I; Blennow K; Ewers M; Hampel H; Iqbal K
Neurosci Lett; 2007 May; 418(2):186-9. PubMed ID: 17400380
[TBL] [Abstract][Full Text] [Related]
11. Intellectual functioning of childhood leukemia survivors--relation to Tau protein--a marker of white matter injury.
Krawczuk-Rybak M; Grabowska A; Protas PT; Muszynska-Roslan K; Holownia A; Braszko J
Adv Med Sci; 2012; 57(2):266-72. PubMed ID: 23154429
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intrathecal chemotherapy in patients with central nervous system involvement of hematological malignancies: a retrospective analysis.
Dara A; Mook BB; Doorduijn JK; van den Bent MJ; Dinmohamed AG; Bromberg JEC
J Neurooncol; 2018 Aug; 139(1):117-123. PubMed ID: 29633110
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal changes of CSF biomarkers in Alzheimer's disease.
Seppälä TT; Koivisto AM; Hartikainen P; Helisalmi S; Soininen H; Herukka SK
J Alzheimers Dis; 2011; 25(4):583-94. PubMed ID: 21460434
[TBL] [Abstract][Full Text] [Related]
14. Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.
Álvarez I; Aguilar M; González JM; Ysamat M; Lorenzo-Bosquet C; Alonso A; Tartari JP; Romero S; Diez-Fairen M; Carcel M; Pujalte F; Pastor P
J Alzheimers Dis; 2018; 61(1):135-143. PubMed ID: 29154286
[TBL] [Abstract][Full Text] [Related]
15. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?
Blennow K; Wallin A; Agren H; Spenger C; Siegfried J; Vanmechelen E
Mol Chem Neuropathol; 1995 Dec; 26(3):231-45. PubMed ID: 8748926
[TBL] [Abstract][Full Text] [Related]
16. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group.
Shoji M; Matsubara E; Murakami T; Manabe Y; Abe K; Kanai M; Ikeda M; Tomidokoro Y; Shizuka M; Watanabe M; Amari M; Ishiguro K; Kawarabayashi T; Harigaya Y; Okamoto K; Nishimura T; Nakamura Y; Takeda M; Urakami K; Adachi Y; Nakashima K; Arai H; Sasaki H; Kanemaru K; Yamanouchi H; Yoshida Y; Ichise K; Tanaka K; Hamamoto M; Yamamoto H; Matsubayashi T; Yoshida H; Toji H; Nakamura S; Hirai S
Neurobiol Aging; 2002; 23(3):363-70. PubMed ID: 11959397
[TBL] [Abstract][Full Text] [Related]
18. CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma.
Sandlund JT; Murphy SB; Santana VM; Behm F; Jones D; Berard CW; Furman WL; Ribeiro R; Crist WM; Greenwald C; Chen G; Walter A; Pui CH
J Clin Oncol; 2000 Aug; 18(16):3018-24. PubMed ID: 10944136
[TBL] [Abstract][Full Text] [Related]
19. Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.
Lewczuk P; Lelental N; Lachmann I; Holzer M; Flach K; Brandner S; Engelborghs S; Teunissen CE; Zetterberg H; Molinuevo JL; Mroczko B; Blennow K; Popp J; Parnetti L; Chiasserini D; Perret-Liaudet A; Spitzer P; Maler JM; Kornhuber J
J Alzheimers Dis; 2017; 55(1):159-170. PubMed ID: 27662295
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.
Andreasen N; Vanmechelen E; Van de Voorde A; Davidsson P; Hesse C; Tarvonen S; Räihä I; Sourander L; Winblad B; Blennow K
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):298-305. PubMed ID: 9527138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
